SUMMARY Plasma malondialdehyde-like material (MDA-LM) was evaluated in 138 normal subjects and in a group of 57 stroke patients using a modification of the method of Smith et al. (1976). The basal level of MDA-LM in the control group was 35 pmol/l with a range of 22-50 pmol/l. Values above 50 timol/l were found in 80% of the patients suffering from subarachnoid haemorrhage, in 68 % of those with cerebral thrombosis, and in 17 % with transient ischaemic attacks. None of the patients with cerebral embolism, intracerebral haematoma, or lacunar infarct had values above 50 umol/l. Significant statistical differences were found between the control group and all the patients except those with lacunar infarcts.
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The laboratory techniques generally used in the diagnosis of thrombosis are based on changes in coagulation and fibrinolytic activity, and on the measurement of platelet-released products in plasma as an index of platelet activation.' Although the fibrinopeptide A assay2 is more sensitive than evaluation of the platelet-released products in the detection of hypercoagulable states and intravascular thrombosis,3 in some conditions, for example, arterial thrombosis, its measurement could be less meaningful. Platelet factor 4 (PF4) and f-thromboglobulin (PTG) tests for the diagnosis of intravascular thrombosis require radioimmunoassay techniques4 which are not available in all laboratories. PF4 evaluation of antiheparin activity has low specificity.5 Therefore we decided to look for other simple techniques to detect platelet activation in vivo.
Thrombin and other inductors of platelet aggregation release arachidonic acid from the phospholipids of platelets.6 This acid is later metabolised by a cyclo-oxygenase, resulting in cyclic endoperoxides (PGG2, PGH2) which are then rapidly converted to stable prostaglandins (PGE2, PGF2, PGD2), thromboxanes, CG7-hydroxyacid (HHT), and malondialdehyde (MDA).7 8 MDA determination has been suggested as a convenient assay for the evaluation of platelet function,9-11 as a method to monitor the action of new antiplatelet drugs,712 as a useful parameter for the control of aspirin therapy, 13 and Received for publication 10 18 An increase in plasma MDA was found in both clinical'9 and experimental20 chronic inflammatory processes as well as in ,-thalassaemia major.2' Therefore, one cannot assume that an increase in plasma MDA-LM should necessarily be related to a platelet activation process, although an increase in plasma MDA-LM has been detected in experimental stroke and in patients with the sequelae of cerebrovascular disorders.22 23 Owing to the clinical difficulties sometimes found not only in the detection of thromboembolism but also in the differential diagnosis of the various types of stroke patient,24 we decided to study plasma MDA-LM in those patients to see if there is a correlation between plasma MDA-LM concentration and the aetiology of stroke.
Material
The study comprised 138 (6) , cerebral embolism (6), intracerebral haematoma (6), and subarachnoid haemorrhage (5) .
Venous blood was obtained within four days of the onset of the acute event, mixed with 3-8 sodium citrate in a ratio of 9:1 v/v and centrifuged for 15 minutes at 1000 g to obtain platelet poor plasma (PPP). MDA-LM was determined by a modification of the method of Smith et al.9 1 ml of 100% w/v trichloroacetic acid in 0-6 M hydrochloric acid and 0-2 ml of thiobarbituric acid (TBA) reagent were added to duplicates of 0 1 ml PPP in 0-45 ml of isotonic saline. The TBA reagent was prepared as in Smith's method.9 After thorough agitation in a vortex mixer, the samples were heated for 30 minutes in a boiling water bath. After cooling to room temperature, the samples were diluted with 2 ml of distilled water, agitated, and centrifuged in order to obtain a clear solution. The optical density of the pink chromogen To quantify the plasma MDA-LM, calibration curves were made with MDA standard in isotonic saline using appropriate dilutions of an MDA stock solution. The molar extinction coefficient was 15 105. The recovery of MDA from plasma was 770% (SD = 8-66, n = 66) of that from saline solution; this was taken into account when evaluating the samples. The intra-assay coefficient of variation was 6%. The day-to-day coefficient of variation was 11 %.
The plasma values of MDA-LM from the normal subjects were arranged as a percentile cumulative frequency (Figure) . Student's t test was used as the statistical method.
During the experimental study the laboratory technicians were unaware of the patients' diagnoses, and clinicians who made the diagnoses were unaware of the MDA-LM results when grouping the patients.
Results
The mean value of plasma MDA-LM in the control group was 35 /imol/1 (n = 138), range 22-50 pmol/l.
The plasma MDA-LM was found to be above 50 
